Global Trust Asset Management, LLC Organon & Co. Transaction History

Global Trust Asset Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	SELL	$17.45 - $21.96 $418 - $527	-24 Reduced 32.0%	51 $1,000
Q1 2024 Apr 12, 2024	SELL	$13.78 - $18.8 $68 - $94	-5 Reduced 6.25%	75 $1,000
Q4 2023 Jan 16, 2024	SELL	$10.95 - $17.32 $10 - $17	-1 Reduced 1.23%	80 $1,000
Q3 2023 Oct 12, 2023	SELL	$16.59 - $23.77 $2,853 - $4,088	-172 Reduced 67.98%	81 $1,000
Q1 2023 Apr 14, 2023	SELL	$21.42 - $32.08 $128 - $192	-6 Reduced 2.32%	253 $5,000
Q4 2022 Feb 14, 2023	SELL	$23.31 - $28.61 $4,452 - $5,464	-191 Reduced 42.44%	259 $7,000
Q3 2022 Oct 07, 2022	SELL	$23.4 - $34.25 $163 - $239	-7 Reduced 1.53%	450 $11,000
Q2 2022 Jul 12, 2022	SELL	$31.66 - $38.9 $379 - $466	-12 Reduced 2.56%	457 $15,000
Q1 2022 Apr 12, 2022	SELL	$30.45 - $39.36 $609 - $787	-20 Reduced 4.09%	469 $16,000
Q4 2021 Jan 18, 2022	SELL	$28.67 - $37.13 $344 - $445	-12 Reduced 2.4%	489 $15,000
Q3 2021 Oct 07, 2021	BUY	$28.63 - $35.64 $14,343 - $17,855	501 New	501 $16,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Global Trust Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Global Trust Asset Management, LLC with notifications on news.